Sponsored
Lilly's Foundayo approved, shares jump 5.4%! Novo ADRs dip 2.6% as pill race heats up. Market eyes $100B by 2030.
DOCN up 45% despite mixed results. SNOW, MDB, CVLT stocks dip post-earnings beats.
P&C insurers saw 2.9% revenue beats, but stocks fell 6.6%. RLI, FAF, ORI, AGO, LMND mixed results.
Intel buys back Ireland stake for $14.2B, boosting stock 9%. Turnaround efforts show promise.
HCA & ABT: Healthcare giants with strong moats & consistent earnings, poised for long-term returns despite regulatory risks.
Personal care stocks mixed Q4; revenues beat, but shares down 9.8%. IPAR, ELF, MED, EL, EPC see varied results.
Bitcoin bonds get Ba2 rating from Moody's, signaling speculative risk but market milestone. Advance rate: 72.06%.
Sponsored
Must Read